Claritev Corporation Q2 2026 Earnings Recap

Claritev's stock surged 21.4% following an earnings report that beat expectations on key metrics including bookings and revenue, driven by strong momentum in the third-party administrator (TPA) segment and expanding opportunities in Medicare Advantage.

Key Takeaways

• Bookings exceeded $74 million in the first half of 2026, well on track for the $100 million full year stretch target.
• The TPA segment led new bookings with multiple 7-figure deals, accounting for roughly 30% of total new bookings and showing immediate progress under new leadership.
• Revenue and adjusted EBITDA both came in above plan, validating the company’s transformation strategy and operational execution.
• Growth is supported by increasing deal sizes, improved win rates, and a healthy sales pipeline across core and emerging verticals.
• Emerging Medicare Advantage opportunities reflect the company’s successful diversification strategy, expanding its addressable market beyond traditional segments.